针对固体瘤中的ATR途径:改善治疗结果的证据
Dimitra Mavroeidi1,2, Anastasia Georganta2, Emmanouil Panagiotou2
1Institute of Chemical Biology, National Hellenic Research Foundation, 116 35 Athens, Greece.
International journal of molecular sciences
|March 13, 2024
概括
抑制ATR激酶会破坏DNA修复,并增强抗瘤免疫力. 这一策略显示了改善癌症治疗的希望,通过向DNA损伤反应和免疫系统相互作用来改善癌症治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- DNA损伤反应 (DDR) 网络对于保持基因组稳定至关重要,涉及ATR和ATM等激酶.
- ATR通路调节复制应激,分叉稳定,细胞循环停止和DNA修复.
研究的目的:
- 审查ATR激酶抑制对DDR网络和免疫系统的影响.
- 探索ATR抑制剂作为一种新型抗瘤治疗策略的潜力.
主要方法:
- 对癌症研究中ATR抑制的最新数据的综述.
- 分析ATR在合成致死性和免疫系统激活中的作用.
主要成果:
- 抑制ATR会破坏DNA修复,导致DNA损伤的积累和复制叉的崩.
- 在ATM缺乏的癌症中,ATR抑制可以诱导合成致死性.
- 通过增加瘤突变负担,新抗原负载和激活cGAS-STING通路,ATR抑制可以增强抗瘤免疫力.
结论:
- 抑制ATR激酶对DDR网络和免疫系统有深远的影响.
- ATR抑制剂提供了一个有希望的治疗策略,作为单一疗法或组合治疗,以提高抗瘤疗效.
关键词:
这是一个ATRATRATRATR.这是一种ATR抑制剂.这是一个ATR-ATM互动.对DNA损伤的反应反应锡拉拉塞尔提布 (AZD6738) 的使用情况免疫系统 免疫系统合成杀伤性 合成杀伤性更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.8K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
